Protalix BioTherapeutics ... (PLX)

AI Score

Unlock

2.39

-0.21 (-8.08%)

At close: Apr 04, 2025, 1:15 PM

Protalix BioTherapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002	FY 2001	FY 2000	FY 1999	FY 1998	FY 1997	FY 1996
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003	Dec 31, 2002	Dec 31, 2001	Dec 31, 2000	Dec 31, 1999	Dec 31, 1998	Dec 31, 1997	Dec 31, 1996
Cash & Equivalents	19.76M	23.63M	17.11M	38.98M	18.27M	17.79M	37.81M	51.16M	63.28M	76.37M	54.77M	86.4M	52.03M	27M	35.9M	81.27M	42.6M	61.81M	15.38M	985.24K	563.71K	179.48K	807.64K	915.63K	390.74K	407.47K	1.29M	547.94K	763.97K
Short-Term Investments	15.07M	20.93M	5.07M	38.98M	20.28M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	552.36K	n/a	n/a	1.22M	1.06M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	462K	528K	1.27M	2.08M	1.8M	1.96M	1.76M	1.89M	1.68M	1.63M	1.67M	1.72M	1.25M	n/a	942K	724K	581K	464K	293K	n/a	n/a	n/a	43.26K	67.06K	105.3K	512.42K	1.27M	n/a	n/a
Receivables	2.91M	5.27M	4.59M	3.44M	2M	4.7M	4.73M	1.72M	693K	n/a	1.88M	2.09M	1.41M	1.37M	9.24M	2.14M	793K	1.35M	1.34M	232K	n/a	n/a	n/a	n/a	n/a	n/a	1.11M	n/a	1.34K
Inventory	21.24M	19.05M	16.8M	17.95M	13.08M	8.15M	8.57M	7.83M	5.25M	5.77M	6.67M	7.96M	4.04M	279K	1.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	596K	611K	536K	380K	1.25M	1.52M	1.42M	1.5M	2.23M	3.33M	2.2M	1.17M	3.44M	3.6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	191.18K	174.6K	n/a	6.88M	6.57M
Total Current Assets	60.08M	69.93M	44.88M	61.67M	55.72M	32.48M	52.98M	62.65M	71.87M	85.88M	65.52M	97.9M	61.17M	32.49M	46.33M	83.41M	43.39M	63.17M	24.29M	987.36K	565.84K	734.25K	831.96K	956.13K	1.8M	1.64M	2.59M	7.43M	7.33M
Property-Plant & Equipment	10.02M	10.88M	9.64M	9.92M	10.41M	10.95M	6.39M	7.68M	8.7M	9.74M	11.28M	13.71M	16.31M	18.27M	17.45M	14.54M	6.84M	4.51M	2.4M	n/a	n/a	n/a	n/a	n/a	n/a	-108.1K	839.19K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	13.34M	14.5M	10.91M	12M	12.21M	12.91M	8.15M	9.56M	10.38M	11.37M	12.95M	15.43M	17.56M	19.31M	18.4M	15.26M	7.42M	4.97M	2.7M	n/a	n/a	n/a	43.26K	67.06K	105.3K	404.32K	2.19M	41.22K	8.47K
Total Assets	73.42M	84.43M	55.79M	73.67M	67.93M	45.39M	61.13M	72.21M	82.25M	97.25M	78.47M	113.33M	78.73M	51.8M	64.73M	98.67M	50.81M	68.14M	26.99M	987.36K	565.84K	734.25K	875.22K	1.02M	1.9M	2.05M	4.77M	7.47M	7.34M
Account Payables	4.53M	4.32M	5.86M	6.99M	7.22M	6.5M	5.21M	7.52M	4.01M	3.63M	3.84M	5.25M	5.27M	5.03M	6.27M	3.41M	2.23M	899K	892K	426K	4K	78.82K	79.07K	77.28K	486.78K	327.7K	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	13.18M	8.55M	5.39M	16.34M	9.87M	26.85M	837K	504K	6.76M	9.37M	9.44M	6.12M	4.56M	4.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.5M	21.66M	1.12M	1.21M	58.51M	4.3M	n/a	5.92M	53.87M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	57.83K	16.2K	n/a	n/a
Other Current Liabilities	1.81M	4.94M	9.94M	13.14M	12.47M	10.52M	9.18M	526K	1.4M	5.98M	14.37M	10.52M	9.3M	1.22M	8.07M	13.56M	1.9M	n/a	n/a	-772.07K	n/a	n/a	n/a	n/a	73.83K	73.83K	181.83K	n/a	n/a
Total Current Liabilities	25.62M	45.53M	32.43M	33.18M	86.47M	40.17M	25.35M	22.75M	66.21M	11.23M	26.21M	26.7M	25.75M	18.69M	18.9M	21.53M	5.53M	3.76M	2.27M	72.93K	70.47K	78.82K	79.07K	77.28K	560.61K	459.36K	1.37M	88.85K	79.96K
Long-Term Debt	4.03M	n/a	28.19M	27.89M	n/a	50.96M	47.97M	46.27M	23.64M	72.1M	67.46M	67.05M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	47.94K	n/a	n/a
Other Long-Term Liabilities	559K	714K	1.64M	2.47M	2.31M	3.07M	7.67M	7.64M	2.35M	2.3M	3.17M	4.74M	7.44M	8.27M	1.66M	1.21M	937K	690K	436K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.38M	7.26M
Total Long-Term Liabilities	4.58M	5.33M	34M	46.52M	8.5M	75.54M	88.66M	80.75M	25.99M	75.14M	107.86M	113.58M	56.33M	59.19M	57.15M	61.26M	937K	690K	436K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	47.94K	7.38M	7.26M
Total Liabilities	30.21M	50.87M	66.43M	79.7M	94.97M	115.71M	114.01M	103.51M	92.2M	86.38M	134.07M	140.28M	82.08M	77.88M	76.05M	82.79M	6.46M	4.45M	2.7M	72.93K	70.47K	78.82K	79.07K	77.28K	560.61K	459.36K	1.42M	7.47M	7.34M
Total Debt	5.53M	26.28M	33.47M	33.47M	64.4M	60.92M	47.97M	52.19M	77.52M	72.1M	67.46M	67.05M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	57.83K	64.14K	n/a	n/a
Common Stock	76K	73K	54K	46K	35K	15K	148K	144K	124K	100K	94K	93K	93K	86K	81K	81K	76K	76K	62K	583.00	292.00	292.00	292.00	292.00	393.00	420.00	588.00	n/a	n/a
Retained Earnings	-378.39M	-381.55M	-389.86M	-374.93M	-347.35M	-340.83M	-322.55M	-297.93M	-212.66M	-183.29M	-241.33M	-211.38M	-183.59M	-171.98M	-135.45M	-106.45M	-75.01M	-42.99M	-20.51M	-3.81M	-3.74M	-3.58M	-3.44M	-3.29M	-2.96M	-2.85M	-1.85M	n/a	n/a
Comprehensive Income	n/a	n/a	n/a	0.00	n/a	n/a	-29.12M	-27.46M	-25.6M	-183.29M	-241.33M	-18.32M	-14.79M	-11.15M	-7.59M	-4.7M	-2.91M	-1.62M	355K	n/a	n/a	n/a	n/a	n/a	-108.03K	-86.74K	n/a	n/a	n/a
Shareholders Equity	43.21M	33.57M	-10.64M	-6.04M	-27.04M	-70.32M	-52.88M	-31.29M	-9.96M	10.87M	-55.6M	-26.95M	-3.36M	-26.08M	-11.32M	15.88M	44.35M	63.69M	24.28M	914.43K	495.36K	655.43K	796.15K	945.91K	1.34M	1.59M	3.35M	n/a	n/a
Total Investments	15.07M	20.93M	5.07M	38.98M	20.28M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	552.36K	n/a	n/a	1.22M	1.06M	n/a	n/a	n/a